Segui
Oscar Sotolongo-Grau
Oscar Sotolongo-Grau
ACE Alzheimer Center Barcelona, Barcelona, Spain
Email verificata su fundacioace.org - Home page
Titolo
Citata da
Citata da
Anno
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
12212022
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373, 2017
9502017
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
2142021
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project
S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ...
Alzheimer's & Dementia 15 (10), 1333-1347, 2019
1512019
Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene
A Ruiz, S Heilmann, T Becker, I Hernández, H Wagner, M Thelen, ...
Translational psychiatry 4 (2), e358-e358, 2014
1302014
Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
A Lacour, A Espinosa, E Louwersheimer, S Heilmann, I Hernández, ...
Molecular psychiatry 22 (1), 153-160, 2017
1162017
New insights on the genetic etiology of Alzheimer’s and related dementia
C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ...
MedRxiv, 2020.10. 01.20200659, 2020
732020
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
V Pérez-Grijalba, J Arbizu, J Romero, E Prieto, P Pesini, L Sarasa, ...
Alzheimer's research & therapy 11, 1-9, 2019
522019
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ...
Alzheimer's Research & Therapy 10, 1-12, 2018
472018
Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer’s disease individuals: replication of diastolic blood pressure correlations and analysis of …
A Ruiz, P Pesini, A Espinosa, V Pérez-Grijalba, S Valero, ...
PLoS One 8 (11), e81334, 2013
472013
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy …
S Moreno–Grau, O Rodríguez‐Gómez, A Sanabria, A Pérez‐Cordón, ...
Alzheimer's & Dementia 14 (5), 634-643, 2018
42*2018
The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline
A Sanabria, M Alegret, O Rodriguez-Gomez, S Valero, O Sotolongo-Grau, ...
Scientific Reports 8 (1), 3828, 2018
422018
Retinal microperimetry: a new tool for identifying patients with type 2 diabetes at risk for developing Alzheimer disease
A Ciudin, O Simó-Servat, C Hernández, G Arcos, S Diego, Á Sanabria, ...
Diabetes 66 (12), 3098-3104, 2017
412017
Tissue radiation response with maximum Tsallis entropy
O Sotolongo-Grau, D Rodriguez-Perez, JC Antoranz, O Sotolongo-Costa
Physical review letters 105 (15), 158105, 2010
412010
Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment
M Alegret, G Cuberas-Borrós, A Espinosa, S Valero, I Hernández, A Ruíz, ...
Journal of Alzheimer's Disease 41 (3), 739-748, 2014
392014
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: a European Alzheimer's disease Consortium study
P Bosco, A Redolfi, M Bocchetta, C Ferrari, A Mega, S Galluzzi, M Austin, ...
Alzheimer's & Dementia 13 (9), 1013-1023, 2017
382017
Assessment of cancer immunotherapy outcome in terms of the immune response time features
D Rodriguez-Perez, O Sotolongo-Grau, RE Riquelme, O Sotolongo-Costa, ...
Mathematical medicine and biology: a journal of the IMA 24 (3), 287-300, 2007
382007
FACEHBI: A prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. Study rationale and research protocols
O Rodriguez-Gomez, A Sanabria, A Perez-Cordon, D Sanchez-Ruiz, ...
J Prev Alzheimers Dis 4 (2), 100-108, 2017
372017
Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
M Marquié, S Valero, M Castilla-Marti, J Martínez, O Rodríguez-Gómez, ...
Alzheimer's research & therapy 12, 1-14, 2020
362020
Early detection of amyloid load using 18F-florbetaben PET
S Bullich, N Roé-Vellvé, M Marquié, SM Landau, H Barthel, ...
Alzheimer's research & therapy 13, 1-15, 2021
352021
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20